Home › NDC Lookup › RxCUI directory › RxCUI 581531

Tigecycline 50 MG Injection — RxCUI 581531

Name: Tigecycline 50 MG Injection (RxCUI 581531)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 581531 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI581531

Official nameTigecycline 50 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped8

Package NDCs mapped8

Reported Medicaid activity (SDUD)794 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Tigecycline Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Tigecycline (Tygacil) is only available as an IV infusion — there's no pill form. It's used specifically for serious bacterial infections that need to be treated in a hospital sett...
Why am I getting this antibiotic instead of a pill I can take at home?
It's completely understandable to be concerned, and I want to be honest with you about it. Clinical trial data did show that patients on tigecycline had a slightly higher death rat...
I heard this antibiotic has a warning about death — should I be worried?

📖 Read our full Tigecycline Injection guide →

🕸️ Concept Web — How Tigecycline 50 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Tigecycline 50 MG Injection RxCUI 581531 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Tigecycline 384455 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Tygacil 584198 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Tigecycline Injection 1724329 SCDF
- Tigecycline Injectable Product 1162095 SCDG
- Tigecycline Injection [Tygacil] 1724332 SBDF
- Tygacil Injectable Product 1186913 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Tigecycline 50 MG 1724328 SCDC
- Tigecycline 50 MG Injection [Tygacil] 584201 SBD
- Tigecycline 50 MG [Tygacil] 1724331 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Tigecycline 50 MG SCDC · 1724328
Tigecycline Injection SCDF · 1724329
Tigecycline Injectable Product SCDG · 1162095

Brand-Name Concepts

Tigecycline 50 MG Injection [Tygacil] SBD · 584201
Tigecycline 50 MG [Tygacil] SBDC · 1724331
Tigecycline Injection [Tygacil] SBDF · 1724332
Tygacil Injectable Product SBDG · 1186913
Tygacil BN · 584198

📦 FDA Products & Package NDCs

8 products · 8 package NDCs

8 package NDCs map to RxCUI 581531 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00008-4990-20	10 VIAL, SINGLE-DOSE in 1 CARTON (0008-4990-20) / 5 mL in 1...	Tygacil	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	2009-09-30
00008-4994-20	10 VIAL, SINGLE-DOSE in 1 CARTON (0008-4994-20) / 5 mL in 1...	Tygacil	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	2017-02-08
00781-3481-92	10 VIAL, SINGLE-DOSE in 1 CARTON (0781-3481-92) / 10 mL in...	Tigecycline	Sandoz Inc	2017-11-30
55150-0228-10	10 VIAL, SINGLE-DOSE in 1 CARTON (55150-228-10) / 1 INJECTI...	Tigecycline	Eugia US LLC	2019-06-11
60505-6098-01	10 VIAL, SINGLE-USE in 1 CARTON (60505-6098-1) / 5 mL in 1...	Tigecycline	Apotex Corp	2019-04-09
70121-1647-07	10 VIAL in 1 CARTON (70121-1647-7) / 5 mL in 1 VIAL (70121-...	Tigecycline	Amneal Pharmaceuticals LLC	2018-01-31
71288-0019-11	10 VIAL, SINGLE-DOSE in 1 CARTON (71288-019-11) / 5 mL in 1...	Tigecycline	Meitheal Pharmaceuticals Inc.	2021-05-13
71288-0019-92	10 VIAL, SINGLE-DOSE in 1 CARTON (71288-019-92) / 5 mL in 1...	Tigecycline	Meitheal Pharmaceuticals Inc.	2026-04-01

Observed labelers: Meitheal Pharmaceuticals Inc. (2) · Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. (2) · Amneal Pharmaceuticals LLC (1) · Apotex Corp (1) · Eugia US LLC (1) · Sandoz Inc (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J3243	Tigecycline injection	7	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.